Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies
- PMID:18951909
- DOI: 10.1016/j.neuropharm.2008.09.018
Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies
Abstract
5-HT(1A) receptors were studied via [(3)H]WAY-100635 and [(3)H]8-OH-DPAT binding to rat brain cortical membranes. We characterized the effect of zinc (Zn(2+)) on the binding properties of the 5-HT(1A) receptor. The allosteric ternary complex model was applied to determine the dissociation constant (K(A)) of Zn(2+) and their cooperativity factors (alpha) affecting the dissociation constants (K(D), K(i)) of [(3)H]WAY-100635, [(3)H]8-OH-DPAT, and serotonin (5-HT), the endogenous neurotransmitter. Zn(2+) (5microM-1mM) inhibited the binding of agonist/antagonist to 5-HT1A receptors, mostly by decreasing both the ligands' affinity and the maximal number of sites. In [(35)S]GTPgammaS binding assays Zn(2+) behaved as insourmountable antagonist of 5-HT1A receptors, in agreement with radioligand binding assays. The residues involved in the formation of the inhibitory binding site on the 5-HT1A receptor were assessed by using N-ethyl-maleimide (NEM) or diethylpyrocarbonate (DEPC) which modify preferentially cysteine and histidine residues, respectively. Exposure to both agents did not block the negative allosteric effects of Zn(2+) on agonist and antagonist binding. Our findings represent the first quantitative analysis of allosteric binding interactions for 5-HT(1A) receptors. The physiological significance of Zn(2+) modulation of 5-HT(1A) receptors is unclear, but the colocalization of 5-HT(1A) receptors and Zn(2+) in the nervous system (e.g. in the hippocampus and cerebral cortex) suggests that Zn(2+) released at nerve terminals may modulate signals generated by the 5-HT(1A) receptors in vivo. Finally, these findings suggest that synaptic Zn(2+) may be a factor influencing the effectiveness of therapies that rely on 5-HT(1A) receptor activity.
Similar articles
- Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.Giannaccini G, Betti L, Pirone A, Palego L, Fabiani O, Fabbrini L, Mascia G, Giusti L, Macchia M, Giusiani M, Martini C, Lucacchini A.Giannaccini G, et al.Neurochem Int. 2007 Dec;51(8):496-506. doi: 10.1016/j.neuint.2007.05.010. Epub 2007 May 31.Neurochem Int. 2007.PMID:17602794
- 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.Odagaki Y, Toyoshima R.Odagaki Y, et al.Eur J Pharmacol. 2005 Oct 3;521(1-3):49-58. doi: 10.1016/j.ejphar.2005.07.018. Epub 2005 Sep 21.Eur J Pharmacol. 2005.PMID:16182280
- In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T.Jordan S, et al.Eur J Pharmacol. 2005 Jul 11;517(3):165-73. doi: 10.1016/j.ejphar.2005.05.035.Eur J Pharmacol. 2005.PMID:15985260
- 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.de Boer SF, Koolhaas JM.de Boer SF, et al.Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. doi: 10.1016/j.ejphar.2005.09.065. Epub 2005 Nov 28.Eur J Pharmacol. 2005.PMID:16310183Review.
- The role of 5-HT(1A) receptors in learning and memory.Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O.Ogren SO, et al.Behav Brain Res. 2008 Dec 16;195(1):54-77. doi: 10.1016/j.bbr.2008.02.023. Epub 2008 Feb 20.Behav Brain Res. 2008.PMID:18394726Review.
Cited by
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA.Rock EM, et al.Br J Pharmacol. 2012 Apr;165(8):2620-34. doi: 10.1111/j.1476-5381.2011.01621.x.Br J Pharmacol. 2012.PMID:21827451Free PMC article.
- Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies.Satała G, Duszyńska B, Stachowicz K, Rafalo A, Pochwat B, Luckhart C, Albert PR, Daigle M, Tanaka KF, Hen R, Lenda T, Nowak G, Bojarski AJ, Szewczyk B.Satała G, et al.Mol Neurobiol. 2016 Dec;53(10):6869-6881. doi: 10.1007/s12035-015-9586-3. Epub 2015 Dec 12.Mol Neurobiol. 2016.PMID:26660328Free PMC article.
- Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.Sato S, Huang XP, Kroeze WK, Roth BL.Sato S, et al.Mol Pharmacol. 2016 Dec;90(6):726-737. doi: 10.1124/mol.116.106112. Epub 2016 Oct 17.Mol Pharmacol. 2016.PMID:27754899Free PMC article.
- Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice.Peñasco S, Rico-Barrio I, Puente N, Fontaine CJ, Ramos A, Reguero L, Gerrikagoitia I, de Fonseca FR, Suarez J, Barrondo S, Aretxabala X, García Del Caño G, Sallés J, Elezgarai I, Nahirney PC, Christie BR, Grandes P.Peñasco S, et al.Neuropsychopharmacology. 2020 Jan;45(2):309-318. doi: 10.1038/s41386-019-0530-5. Epub 2019 Sep 30.Neuropsychopharmacology. 2020.PMID:31569197Free PMC article.
- Experimental conditions can obscure the second high-affinity site in LeuT.Quick M, Shi L, Zehnpfennig B, Weinstein H, Javitch JA.Quick M, et al.Nat Struct Mol Biol. 2012 Jan 15;19(2):207-11. doi: 10.1038/nsmb.2197.Nat Struct Mol Biol. 2012.PMID:22245968Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources